Roehrborn CG - Search Results

1

The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.

Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, Montorsi F; CombAT Study Group. Roehrborn CG, et al. J Urol. 2008 Feb;179(2):616-21; discussion 621. doi: 10.1016/j.juro.2007.09.084. Epub 2007 Dec 21. J Urol. 2008. PMID: 18082216 Clinical Trial.

2

Transurethral intravesical electrotherapy for neurogenic bladder dysfunction in children with myelodysplasia: a prospective, randomized clinical trial.

Boone TB, Roehrborn CG, Hurt G. Boone TB, et al. Among authors: roehrborn cg. J Urol. 1992 Aug;148(2 Pt 2):550-4. doi: 10.1016/s0022-5347(17)36651-x. J Urol. 1992. PMID: 1640520 Clinical Trial.

3

A prospective study of urologist-performed sonographic evaluation of the urinary tract in patients with prostatism.

Reisman EM, Kennedy TJ, Roehrborn CG, McConnell JD. Reisman EM, et al. Among authors: roehrborn cg. J Urol. 1991 Jun;145(6):1186-9; discussion 1189-91. doi: 10.1016/s0022-5347(17)38570-1. J Urol. 1991. PMID: 2033690

4

The assessment of medical treatment for benign prostatic hyperplasia (BPH).

Roehrborn CG. Roehrborn CG. Prog Clin Biol Res. 1994;386:175-90. Prog Clin Biol Res. 1994. PMID: 7528385 Review. No abstract available.

5

Objective and subjective response criteria to diagnose benign prostatic hyperplasia.

Roehrborn CG. Roehrborn CG. Eur Urol. 1993;24 Suppl 1:2-11. doi: 10.1159/000474367. Eur Urol. 1993. PMID: 7687554 Review.

6

Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders.

Litwiller SE, Djavan B, Klopukh BV, Richier JC, Roehrborn CG. Litwiller SE, et al. Among authors: roehrborn cg. Urology. 1995 May;45(5):813-22. doi: 10.1016/s0090-4295(99)80089-2. Urology. 1995. PMID: 7747373 Clinical Trial.

7

Analysis of factors contributing to success or failure of 1-stage urethroplasty for urethral stricture disease.

Roehrborn CG, McConnell JD. Roehrborn CG, et al. J Urol. 1994 Apr;151(4):869-74. doi: 10.1016/s0022-5347(17)35109-1. J Urol. 1994. PMID: 8126813

8

Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.

Roehrborn CG, Pickens GJ, Carmody T 3rd. Roehrborn CG, et al. Urology. 1996 Jan;47(1):59-66. doi: 10.1016/s0090-4295(99)80383-5. Urology. 1996. PMID: 8560664

9

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA, Lloyd LK, Milam DE, Padley RJ. Roehrborn CG, et al. Urology. 1996 Feb;47(2):159-68. doi: 10.1016/s0090-4295(99)80409-9. Urology. 1996. PMID: 8607227 Clinical Trial.

10

The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia.

Hillman AL, Schwartz JS, Willian MK, Peskin E, Roehrborn CG, Oesterling JE, Mason MF, Maurath CJ, Deverka PA, Padley RJ. Hillman AL, et al. Among authors: roehrborn cg. Urology. 1996 Feb;47(2):169-78. doi: 10.1016/s0090-4295(99)80410-5. Urology. 1996. PMID: 8607228 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

532 results

Search Page